Our experience and expertise allow us to develop your product quickly and successfully

Developing a softgel isn’t like developing any other formulation, and it brings both unique advantages and challenges to the process. CAPTEK Pharma’s long history of developing softgels means that we understand all the intricacies involved and can develop your product’s formulation quickly and successfully.

CAPTEK Pharma offers end-to-end formulation development. We develop extensive analytical methods customized for your product’s needs. Our robust data-based formulation methods are strategically leveraged at initial softgel development to optimize the benefits of our manufacturing process. Our critical experience in the development and production of softgel technology promotes proactive solutions in creating a formulation that works best for your product. As each molecule requires specific analytical methods to support a particular formulation, CAPTEK Pharma conducts extensive research in the product development stage to generate effective recommendations for a more competent formula. Our legacy of development expertise drives our unmatched capacity to quickly offer scalable solutions that fulfill your market needs.

Formulation & Analytical:
CAPTEK Pharma develops extensive analytical methods to support formulations respective to your product’s needs to minimize the risk of failure during encapsulation. We are proficient in formulating from scratch for the OTC market in creating a formulation that works best for your product.

Clinical Trial Materials:
Clinical trial materials are manufactured under cGMP conditions at our state-of-the-art La Mirada manufacturing facility on the same production equipment used for commercial products therefore we can transition your clinical trial materials to larger production runs with no gap in workflow for scale-up recalibration.

Stability Studies:
Softgels have special stability testing needs that must be addressed, including appearance, color, odor, pH, leakage, precipitation, cloudiness and many other factors. All of our stability studies are developed in accordance with ICH Q1A(R2) stability requirements and the ICH stability guidance using stability chambers qualified under IQ/OQ/PQ standard.

Speak With An Expert

Profile Photo: Tim Chiprich

Tim Chiprich

Product Development Specialist

Over his 25 year career, Tim Chiprich has led teams developing softgel pharmaceuticals, dietary supplements, and cosmetic products. In addition, he’s participated in gelatin research and new technology projects and has several pending and granted patents. Tim is happy to leverage his thorough understanding of softgel development to discuss any challenges on your upcoming project.

Contact Me

What question can I answer for you?

  • Please be specific